Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kamil Musilek

Showing results (51-60 of 199) with videos related to

Pageof 20
Sort By:
Journal of Pharmaceutical and Biomedical Analysis|September 21, 2015
Development and validation of a FIA/UV-vis method for pK(a) determination of oxime based acetylcholinesterase reactivatorsKarel Musil, Veronika Florianova, Pavel Bucek, et al.
Toxicology Letters|July 27, 2015
Investigation of the reactivation kinetics of a large series of bispyridinium oximes with organophosphate-inhibited human acetylcholinesteraseMichael Winter, Timo Wille, Kamil Musilek, et al.
Drug and Chemical Toxicology|June 12, 2009
A comparison of neuroprotective efficacy of newly developed oximes (K203, K206) and commonly used oximes (obidoxime, HI-6) in tabun-poisoned ratsJiri Kassa, Jana Karasova, Libor Vasina, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|April 30, 2014
Preparation, in vitro screening and molecular modelling of monoquaternary compounds related to the selective acetylcholinesterase inhibitor BW284c51Ondrej Benek, Kamil Musilek, Anna Horova, et al.
Analytical and Bioanalytical Chemistry|March 13, 2010
Fluctuation in the ergosterol and deoxynivalenol content in barley and malt during malting processVlastimil Dohnal, Alena Jezkova, Lucie Pavlikova, et al.
European Journal of Medicinal Chemistry|June 10, 2022
Contemporary mTOR inhibitor scaffolds to diseases breakdown: A patent review (2015-2021)Patrik Oleksak, Eugenie Nepovimova, Zofia Chrienova, et al.
Journal of Molecular Graphics & Modelling|January 16, 2015
Ligand-based 3D QSAR analysis of reactivation potency of mono- and bis-pyridinium aldoximes toward VX-inhibited rat acetylcholinesteraseRafael Dolezal, Jan Korabecny, David Malinak, et al.
Bioanalysis|March 29, 2013
LC-MS/MS approaches for the assay of bis-quaternary pyridinium oximes used as AChE reactivators in biological matricesVictor Voicu, Florin Albu, Florentin Tache, et al.
Archives of Toxicology|June 11, 2014
Reactivation kinetics of 31 structurally different bispyridinium oximes with organophosphate-inhibited human butyrylcholinesteraseGabriele Horn, Timo Wille, Kamil Musilek, et al.
Medicinal Research Reviews|March 3, 2020
Recent advances with 5-HT<sub>3</sub> modulators for neuropsychiatric and gastrointestinal disordersRadomir Juza, Premysl Vlcek, Eva Mezeiova, et al.
Pageof 20

Showing results (51-60 of 199) with videos related to

Sort By:
Pageof 20
Journal of Pharmaceutical and Biomedical Analysis|September 21, 2015
Development and validation of a FIA/UV-vis method for pK(a) determination of oxime based acetylcholinesterase reactivatorsKarel Musil, Veronika Florianova, Pavel Bucek, et al.
Toxicology Letters|July 27, 2015
Investigation of the reactivation kinetics of a large series of bispyridinium oximes with organophosphate-inhibited human acetylcholinesteraseMichael Winter, Timo Wille, Kamil Musilek, et al.
Drug and Chemical Toxicology|June 12, 2009
A comparison of neuroprotective efficacy of newly developed oximes (K203, K206) and commonly used oximes (obidoxime, HI-6) in tabun-poisoned ratsJiri Kassa, Jana Karasova, Libor Vasina, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|April 30, 2014
Preparation, in vitro screening and molecular modelling of monoquaternary compounds related to the selective acetylcholinesterase inhibitor BW284c51Ondrej Benek, Kamil Musilek, Anna Horova, et al.
Analytical and Bioanalytical Chemistry|March 13, 2010
Fluctuation in the ergosterol and deoxynivalenol content in barley and malt during malting processVlastimil Dohnal, Alena Jezkova, Lucie Pavlikova, et al.
European Journal of Medicinal Chemistry|June 10, 2022
Contemporary mTOR inhibitor scaffolds to diseases breakdown: A patent review (2015-2021)Patrik Oleksak, Eugenie Nepovimova, Zofia Chrienova, et al.
Journal of Molecular Graphics & Modelling|January 16, 2015
Ligand-based 3D QSAR analysis of reactivation potency of mono- and bis-pyridinium aldoximes toward VX-inhibited rat acetylcholinesteraseRafael Dolezal, Jan Korabecny, David Malinak, et al.
Bioanalysis|March 29, 2013
LC-MS/MS approaches for the assay of bis-quaternary pyridinium oximes used as AChE reactivators in biological matricesVictor Voicu, Florin Albu, Florentin Tache, et al.
Archives of Toxicology|June 11, 2014
Reactivation kinetics of 31 structurally different bispyridinium oximes with organophosphate-inhibited human butyrylcholinesteraseGabriele Horn, Timo Wille, Kamil Musilek, et al.
Medicinal Research Reviews|March 3, 2020
Recent advances with 5-HT<sub>3</sub> modulators for neuropsychiatric and gastrointestinal disordersRadomir Juza, Premysl Vlcek, Eva Mezeiova, et al.
Pageof 20